Beta-propiolactone for inactivation of viruses in pharmaceutical pancreatic enzyme preparations

Details for Australian Patent Application No. 2011228744 (hide)

Owner Aptalis Pharma Canada Inc.

Inventors Tijssen, Peter; Szelei, Jozsef

Agent Shelston IP

Pub. Number AU-A-2011228744

PCT Pub. Number WO2011/114225

Priority 61/315,813 19.03.10 US

Filing date 18 March 2011

Wipo publication date 22 September 2011

International Classifications

C12N 9/14 Enzymes, e.g. ligases (6.) - Hydrolases (3.)

A61K 9/00 Medicinal preparations characterised by special physical form

A61K 38/46 Medicinal preparations containing peptides

A61K 47/12 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

A61K 47/22 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Heterocyclic compounds

A61L 2/16 Disinfection or sterilising - using chemical substances

A61P 1/18 Drugs for disorders of the alimentary tract or the digestive system

Event Publications

11 October 2012 PCT application entered the National Phase

  PCT publication WO2011/114225 Priority application(s): WO2011/114225

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011228751-Herbicide-tolerant plants

2011228743-Gastro-resistant enzyme pharmaceutical compositions